[HTML][HTML] Similar piperacillin/tazobactam target attainment in obese versus nonobese patients despite differences in interstitial tissue fluid pharmacokinetics
D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - Pharmaceutics, 2021 - mdpi.com
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …
[引用][C] Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - Pharmaceutics …, 2021 - jglobal.jst.go.jp
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients
despite Differences in Interstitial Tissue Fluid Pharmacokinetics | Article Information | J-GLOBAL …
despite Differences in Interstitial Tissue Fluid Pharmacokinetics | Article Information | J-GLOBAL …
[PDF][PDF] Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics …
D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - 2021 - scholar.archive.org
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - …, 2021 - search.proquest.com
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics.
D Busse, P Simon, D Petroff, C Dorn… - …, 2021 - search.ebscohost.com
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …
[PDF][PDF] Similar piperacillin/tazobactam target attainment in obese versus nonobese patients despite differences in interstitial tissue fluid pharmacokinetics
D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - 2021 - opus.bibliothek.uni-augsburg.de
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - …, 2021 - refubium.fu-berlin.de
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
D Busse, P Simon, D Petroff, C Dorn… - …, 2021 - epub.uni-regensburg.de
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …
[HTML][HTML] Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - …, 2021 - ncbi.nlm.nih.gov
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics.
D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - …, 2021 - europepmc.org
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse
information on target-site exposure. We aimed to evaluate the appropriateness of current …
information on target-site exposure. We aimed to evaluate the appropriateness of current …